Details
- Status
- Closed
- Opening date
- Deadline
- Department
- Directorate-General for Health and Food Safety
Target audience
Public health community
Why we are consulting
Public consultation
Period of consultation
From 16 April 2012 to 1 June 2012.
Contributions to and results of the consultation
Chongqin Pharmaceutical Research Institute, Dow Corning, Kyongbo, NKF, Qilu, Sandoz and TEVA asked not to publish their responses.
Below are the public responses to the above-mentioned public consultation:
- AEFI - The Spanish Association of Pharmacists in Industry
- AEMPS - Agencia Española de Medicamentos y Productos Sanitario
- AESGP - Association Européenne des Spécialités Pharmaceutiques Grand Public
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- APIC - Active Pharmaceutical Ingredients Committee : [1] - [2]
- Chifeng Arker Pharmaceutical Technology Co., Ltd.
- Bogin
- China Chamber of Commerce of Import & Export
- Domenico Criscuolo, MD, PhD, FFPM
- Yantai Donggheng Biochemicals CO. LTD.
- EFCG/CEFIC
- Autorités françaises (France)
- GBP - Zhejiang Guobang Pharmaceutical Co., Ltd.
- HEC PHARM CO., LTD.
- Hubei Biocause
- ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.
- Kela NV
- Ministry of Health, Welfare and Sport (the Netherlands)
- MHRA - Medicines and Healthcare products Regulatory Agency (UK)
- Northeast Pharmaceutical Group Co., Ltd.
- Nycomed - a Takeda Company
- Orchid Chemicals & Pharmaceuticals Ltd. (India)
- PHARMIG - Association of the Austrian pharmaceutical industrie
- Rambaxy
- R L Fine Chem, Bangalore (India)
- SFDA
- VDC - Drug and Chemicals Association
- Yonsung Fine Chemicals Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd.
The consultation document
The consultation document can be downloaded here.
Protection of personal data
The policy on "protection of individuals with regard to the processing of personal data by the Community institutions" is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. More information is available here.
Specific privacy statement
Please consult the Privacy Statement to be downloaded here.